Cargando…
Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial
Objective To assess the effectiveness and safety of melatonin in treating severe sleep problems in children with neurodevelopmental disorders. Design 12 week double masked randomised placebo controlled phase III trial. Setting 19 hospitals across England and Wales. Participants 146 children aged 3 y...
Autores principales: | Gringras, P, Gamble, C, Jones, A P, Wiggs, L, Williamson, P R, Sutcliffe, A, Montgomery, P, Whitehouse, W P, Choonara, I, Allport, T, Edmond, A, Appleton, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489506/ https://www.ncbi.nlm.nih.gov/pubmed/23129488 http://dx.doi.org/10.1136/bmj.e6664 |
Ejemplares similares
-
Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders
por: Yuge, Kotaro, et al.
Publicado: (2020) -
Effect of melatonin in children with neurodevelopmental disabilities and sleep disorders
por: Al Twaijri, Waleed A., et al.
Publicado: (2022) -
A quasi-placebo may have a role in some randomised controlled trials
por: Whitehouse, William P.
Publicado: (2018) -
Melatonin in Neurodevelopmental Disorders: A Critical Literature Review
por: Feybesse, Cyrille, et al.
Publicado: (2023) -
Melatonin, temazepam and placebo in hospitalised older patients with sleeping problems (MATCH): a study protocol of randomised controlled trial
por: Stenveld, Fiona, et al.
Publicado: (2019)